Rohto Pharmaceutical Co.,Ltd.
4527.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥77,161,000 | ¥89,210,000 | ¥79,951,000 | ¥72,791,000 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥69,880,000 | ¥69,115,000 | ¥60,656,000 | ¥51,682,000 |
| Inventory | ¥61,580,000 | ¥46,657,000 | ¥41,062,000 | ¥33,527,000 |
| Other Curr. Assets | ¥9,258,000 | ¥9,777,000 | ¥8,577,000 | ¥6,306,000 |
| Total Curr. Assets | ¥217,879,000 | ¥214,759,000 | ¥190,246,000 | ¥164,306,000 |
| Property Plant & Equip (Net) | ¥90,451,000 | ¥68,607,000 | ¥66,182,000 | ¥62,839,000 |
| Goodwill | ¥47,494,000 | ¥2,285,000 | ¥2,564,000 | ¥2,954,000 |
| Intangibles | ¥8,575,000 | ¥6,932,000 | ¥6,997,000 | ¥6,338,000 |
| Long-Term Investments | ¥46,427,000 | ¥43,731,000 | ¥32,629,000 | ¥27,471,000 |
| Tax Assets | ¥3,975,000 | ¥3,869,000 | ¥5,371,000 | ¥5,297,000 |
| Other NC Assets | ¥7,074,000 | ¥5,992,000 | ¥5,686,000 | ¥5,419,000 |
| Total NC Assets | ¥203,996,000 | ¥131,416,000 | ¥119,429,000 | ¥110,318,000 |
| Other Assets | ¥0 | ¥3,000 | ¥2,000 | ¥3,000 |
| Total Assets | ¥421,875,000 | ¥346,175,000 | ¥309,677,000 | ¥274,627,000 |
| Liabilities | – | – | – | – |
| Payables | ¥22,056,000 | ¥21,123,000 | ¥18,718,000 | ¥16,269,000 |
| Short-Term Debt | ¥7,035,000 | ¥5,304,000 | ¥4,177,000 | ¥8,033,000 |
| Tax Payable | ¥0 | ¥5,071,000 | ¥6,230,000 | ¥3,185,000 |
| Deferred Revenue | ¥0 | ¥5,071,000 | ¥30,592,000 | ¥22,539,000 |
| Other Curr. Liab. | ¥55,316,000 | ¥24,798,000 | ¥2,313,000 | ¥5,293,000 |
| Total Curr. Liab. | ¥94,608,000 | ¥87,087,000 | ¥80,162,000 | ¥71,488,000 |
| LT Debt | ¥43,188,000 | ¥5,190,000 | ¥7,516,000 | ¥13,350,000 |
| Deferred Rev, NC | ¥0 | ¥1,498,000 | ¥3,146,000 | ¥3,387,000 |
| Deferred Tax Liab, NC | ¥2,081,000 | ¥1,597,000 | ¥1,173,000 | ¥1,450,000 |
| Other NC Liab. | ¥3,370,000 | ¥2,266,000 | ¥2,604,000 | ¥1,037,000 |
| Total NC Liab. | ¥55,825,000 | ¥12,055,000 | ¥14,439,000 | ¥19,311,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥1,498,000 | ¥1,184,000 | ¥1,184,000 |
| Total Liabilities | ¥150,433,000 | ¥99,142,000 | ¥94,601,000 | ¥90,799,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥6,504,000 | ¥6,504,000 | ¥6,504,000 | ¥6,504,000 |
| Retained Earnings | ¥228,442,000 | ¥209,399,000 | ¥184,005,000 | ¥162,195,000 |
| AOCI | ¥35,086,000 | ¥30,843,000 | ¥18,705,000 | ¥8,735,000 |
| Other Equity | ¥2,000 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥260,095,000 | ¥246,323,000 | ¥209,568,000 | ¥178,285,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥11,345,000 | ¥710,000 | ¥5,508,000 | ¥5,543,000 |
| Total Liab. & Tot. Equity | ¥421,875,000 | ¥346,175,000 | ¥309,677,000 | ¥274,627,000 |
| Net Debt | -¥26,938,000 | -¥78,716,000 | -¥68,258,000 | -¥51,408,000 |